González-García Andrés, Fortún Jesús, Elorza Navas Enrique, Martín-Dávila Pilar, Tato Marta, Gómez-Mampaso Enrique, Moreno Santiago
Department of Internal Medicine Department of Infectious Diseases Department of Microbiology, University Hospital Ramón y Cajal, University of Alcalá, IRYCIS, Madrid, Spain.
Medicine (Baltimore). 2017 Jun;96(26):e7219. doi: 10.1097/MD.0000000000007219.
Important epidemiological changes and improvement of new diagnostic approaches, mainly molecular tools, might have impacted the management and outcome of tuberculosis (TB) in the last years in industrialized countries. In order to describe the epidemiological trends, and changes in clinical, diagnostic, and therapeutic aspects in patients with TB, an observational study was performed in a tertiary hospital in Western Europe (Madrid, Spain).All adult patients (>16 years) with a diagnosis of TB in the period 1995 to 2013 were included in the study.TB was diagnosed in 1284 patients, including 304 (24%) foreign-born and 298 (23.2%) human immunodeficiency virus (HIV)-infected patients. The proportion of foreign-born patients increased significantly, from 7.4% (1995) to 40.3% (2013), P < .001, while the proportion of patients with HIV infection decreased (from 41% to 15%, P < .001). Extrapulmonary locations of TB increased (from 23.9% to 37.1%, P < .001), although the miliary forms were less frequent (from 16% to 5.6%, P < .001). Pulmonary involvement remained constant during the period of study (from 50% to 46%, P = .18). The yield of microbiological diagnostic methods in different clinical specimens has remained very similar. Only molecular techniques have improved the diagnosis in respiratory, urinary, and peritoneal samples. The global cure rate was 64.8% and mortality rate was 9.1% (6.5% directly attributable to TB). Mortality has decreased significantly during the years of study (from 11% to 2%, P < .001).There has been a significant decline in the number of patients with TB. Changes in HIV coinfection and immigration have conditioned other epidemiological and clinical aspects of the disease, including the clinical presentation, treatment response, and mortality. Only the use of molecular tests has provided an improvement in the diagnosis of pulmonary and extrapulmonary TB.
在过去几年中,重要的流行病学变化以及新诊断方法(主要是分子工具)的改进可能对工业化国家结核病(TB)的管理和结局产生了影响。为了描述结核病患者的流行病学趋势以及临床、诊断和治疗方面的变化,在西欧的一家三级医院(西班牙马德里)进行了一项观察性研究。
该研究纳入了1995年至2013年期间所有诊断为结核病的成年患者(>16岁)。共诊断出1284例结核病患者,其中包括304例(24%)出生在国外的患者和298例(23.2%)感染人类免疫缺陷病毒(HIV)的患者。出生在国外的患者比例显著增加,从1995年的7.4%增至2013年的40.3%,P<0.001,而HIV感染患者的比例则有所下降(从41%降至15%,P<0.001)。肺外结核的发病部位有所增加(从23.9%增至37.1%,P<0.001),尽管粟粒型结核的发病频率较低(从16%降至5.6%,P<0.001)。在研究期间,肺部受累情况保持稳定(从50%降至46%,P=0.18)。不同临床标本中微生物诊断方法的阳性率一直非常相似。只有分子技术提高了呼吸道、尿液和腹膜样本的诊断率。总体治愈率为64.8%,死亡率为9.1%(6.5%直接归因于结核病)。在研究期间,死亡率显著下降(从11%降至2%,P<0.001)。
结核病患者数量显著下降。HIV合并感染和移民情况的变化影响了该疾病的其他流行病学和临床方面,包括临床表现、治疗反应和死亡率。只有分子检测在肺内和肺外结核病的诊断方面有所改进。